Cargando…

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma

The association between tumor microenvironment (TME) and cancer‐associated fibroblasts (CAFs) in intrahepatic cholangiocarcinoma (ICC) progression is poorly understood. This study aimed to reveal whether specific microRNAs (miRNAs) in extracellular vesicles (EVs) derived from CAFs were involved in I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toshida, Katsuya, Itoh, Shinji, Harada, Noboru, Morinaga, Akinari, Yugawa, Kyohei, Tomiyama, Takahiro, Kosai‐Fujimoto, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Nagao, Yoshihiro, Morita, Kazutoyo, Oda, Yoshinao, Yoshizumi, Tomoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986089/ https://www.ncbi.nlm.nih.gov/pubmed/36369960 http://dx.doi.org/10.1111/cas.15644

Ejemplares similares

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
por: Nagao, Yoshihiro, et al.
Publicado: (2022)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
por: Yugawa, Kyohei, et al.
Publicado: (2021)

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
por: Tomiyama, Takahiro, et al.
Publicado: (2021)

Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report
por: Shiraishi, Jin, et al.
Publicado: (2023)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Solitary fibrous tumor in the liver: case report and literature review
por: Yugawa, Kyohei, et al.
Publicado: (2019)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

C‐reactive protein : albumin ratio in patients with resectable intrahepatic cholangiocarcinoma
por: Matsumoto, T., et al.
Publicado: (2020)

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples
por: Izumi, Takuma, et al.
Publicado: (2021)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

Retroperitoneal schwannoma preoperatively diagnosed as liver metastasis from colon cancer: A case report
por: Wang, Huanlin, et al.
Publicado: (2019)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Murakami, Yoshiki, et al.
Publicado: (2015)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
por: Inoue, Yoshiyuki, et al.
Publicado: (2012)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_92jnojp5mij44jqdh2u7nti7q9